Story
Nov 20, 2026
Anthropic’s record IPO meets a market still wary of the AI boom.
Anthropic’s debut thrilled investors who see a new benchmark for AI companies, even as market jitters and questions about the sector’s valuation and risks temper the celebration. Its supporters also argue that public ownership could bring greater scrutiny and transparency.
Anthropic began preparing investors for a public listing nearly a month before its Nasdaq debut. Its filing reported $16.3 billion in revenue in the first half of the year, alongside a large net loss, much of it attributed to an accounting charge. CEO Dario Amodei also pledged to pace AI development until the company was confident its systems were safe and under human control.1
The company priced shares at $83, then opened at $111.50 on Thursday, raising $81.3 billion in what its backers called a record IPO. Shares closed at $97.17, up about 17% for the day, while the wider market fell. Byron Deeter, a venture investor, said Anthropic had pressed ahead despite a “massively disruptive” market backdrop.2
The first-day jump lifted Anthropic’s value to roughly $1.75 trillion at the close, after an early surge implied a valuation above $2 trillion. Supporters described the listing as a milestone for the AI industry. Lightspeed co-founder Ravi Mhatre said going public brings “transparency” and lets society participate as a stakeholder in the company.3 But the scale also sharpened questions about whether AI stocks are in a bubble; a California legislative analyst warned that a bust could leave severe budget shortfalls.4
The response from peers was celebratory, though not without an appeal for Anthropic to share its success. Perplexity CEO Aravind Srinivas congratulated the company, calling its team “focused” and “high-conviction.”
5 Hugging Face CEO Clement Delangue likewise offered congratulations, while urging the company to support “more open science and open-source AI.”
6
The debut gives Anthropic a vast new pool of capital for AI infrastructure. It also puts the young company under public-market scrutiny, where investors will be watching whether its growth—and its safety promises—can hold up.